The mRNA Victoria Pipeline Program – Round 1 provides grants of up to $1 million to eligible Victorian organisations developing innovative mRNA vaccines and therapeutics. Manufacturing ReadinessProjects should be capable of progressing toward Good Manufacturing Practice (GMP) manufacturing. The mRNA Victoria Pipeline Program – Round 1 offers grants of up to $1 million per eligible project. Manufacturing RequirementProjects must be capable of being manufactured at the BioNTech GMP Clinical Manufacturing Facility or R&D Production Laboratory. ConclusionThe mRNA Victoria Pipeline Program – Round 1 provides up to $1 million to help Victorian organisations accelerate the development of innovative mRNA vaccines and therapeutics.